Seres Therapeutics (MCRB) Priced

Developing therapies that replace beneficial colon bacteria to treat infections.

Health Care - Biotechnology

IPO Performance
Latest Trade $9.71 0.00 (0.0%)
First Day Return 185.6%
Return from IPO -46.1%
 
Seres Therapeutics IPO News more
  • .
IPO Data
IPO File Date 05/27/2015
Offer Price $18.00
Price Range $15.00 - $17.00
Offer Shares (mm) 7.4
Deal Size ($mm) 134
 
IPO Data
IPO Date 06/25/2015
Offer Price $18.00
Price Range $15.00 - $17.00
Offer Shares (mm) 7.4
Deal Size ($mm) $134
 
Underwriters
more
Business Overview
Developing therapies that replace beneficial colon bacteria to treat infections.
Developing therapies that replace beneficial colon bacteria to treat infections.
more
Company Data
Headquarters Cambridge, MA
Founded 2010
Employees 46
Website www.serestherapeutics.com
 

Performance vs. IPO Index (IPOUSA)